Pharmaceutical Trade Trends

Japan's pharmaceutical (HS Chapter 30) import/export data, top trading partners, and monthly trends from real-time trade statistics.

この品目を解説 →
Chapter (2-digit)

30Pharmaceutical products

医療用品

HS code 30 is a Chapter (2-digit) classification number. In Japan's trade statistics (published by Ministry of Finance), it represents import/export items classified as Pharmaceutical products. This code has 6 subcategories defined below it.

Latest trade statistics

In May 2026, Japan's imports under HS code 30 (Pharmaceutical products) totaled ¥467B (YoY +9.0%), with a volume of 6,919,475 KG at about ¥67,436/KG. The top import sources are United States of America (22.4%), Ireland (14.3%), Germany (13.6%). Exports totaled ¥107B (YoY +10.0%), with a volume of 4,685,288 KG at about ¥22,926/KG. The top export destinations are United States of America (29.1%), Switzerland (20.8%), People's Republic of China (18.6%).

Export (May 2026)
¥107B
YoY: +10.0%
Qty: 4,685,288 KG
Unit price: ¥22,926/KG
Import (May 2026)
¥467B
YoY: +9.0%
Qty: 6,919,475 KG
Unit price: ¥67,436/KG

Top export destinations (2025)

#CountryValueShareQtyUnit price
1United States of America¥364B29.1%9,288,752¥39,227
2Switzerland¥259B20.8%144,243¥1,798,637
3People's Republic of China¥233B18.6%11,511,437¥20,198
4Republic of Korea¥52B4.2%12,503,242¥4,172
5Taiwan¥49B3.9%3,123,405¥15,611

Top import sources (2025)

#CountryValueShareQtyUnit price
1United States of America¥1T22.4%9,386,848¥116,622
2Ireland¥696B14.3%821,546¥846,727
3Germany¥664B13.6%4,109,698¥161,603
4Switzerland¥414B8.5%607,231¥681,896
5United Kingdom¥222B4.6%4,689,682¥47,425

Subcategories6items

Heading (4-digit)
3001Glands and other organs for organo-therapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included:
Heading (4-digit)
3002Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified:
Heading (4-digit)
3003Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale:
Heading (4-digit)
3004Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale:
Heading (4-digit)
3005Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes:
Heading (4-digit)
3006Pharmaceutical goods specified in Note 4 to this Chapter:

Analyze trade data with HS codes

Analyze import/export statistics based on official Ministry of Finance data with country share, trend analysis, predictions, and more. Get started with a free account.